Literature DB >> 29079161

Hepatitis C Virus Infection in the Older Patient.

Michael Reid1, Jennifer C Price1, Phyllis C Tien2.   

Abstract

Hepatitis C virus (HCV) is the most common blood-borne infection in the United States and is of concern in older adults. HCV infection is associated with not only hepatic but also extrahepatic comorbidities common to the aging patient including diabetes, kidney and cardiovascular diseases, and neurocognitive impairment. The effect of direct-acting antiviral agents to treat HCV on these outcomes is limited. This article summarizes the literature regarding the epidemiology and natural history of HCV infection; the impact of age on clinical outcomes in HCV-infected persons; and current knowledge regarding safety and efficacy of HCV treatment regimens in the older patient.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Aging; Comorbidity; HCV; Inflammation

Mesh:

Substances:

Year:  2017        PMID: 29079161      PMCID: PMC5675560          DOI: 10.1016/j.idc.2017.07.014

Source DB:  PubMed          Journal:  Infect Dis Clin North Am        ISSN: 0891-5520            Impact factor:   5.982


  64 in total

1.  Increased frequency of late-senescent T cells lacking CD127 in chronic hepatitis C disease.

Authors:  Muttiah Barathan; Rosmawati Mohamed; Alireza Saeidi; Jamuna Vadivelu; Li Y Chang; Kaliappan Gopal; Mani R Ram; Abdul W Ansari; Adeeba Kamarulzaman; Vijayakumar Velu; Marie Larsson; Esaki M Shankar
Journal:  Eur J Clin Invest       Date:  2015-03-16       Impact factor: 4.686

2.  Burden of Hepatitis C Virus Infection Among Older Adults in Long-Term Care Settings: a Systematic Review of the Literature and Meta-Analysis.

Authors:  Kimberly J Alvarez; Arlene Smaldone; Elaine L Larson
Journal:  Curr Infect Dis Rep       Date:  2016-03       Impact factor: 3.725

3.  Serum lipid pattern in chronic hepatitis C: histological and virological correlations.

Authors:  D Siagris; M Christofidou; G J Theocharis; N Pagoni; C Papadimitriou; A Lekkou; K Thomopoulos; I Starakis; A C Tsamandas; C Labropoulou-Karatza
Journal:  J Viral Hepat       Date:  2006-01       Impact factor: 3.728

4.  Previous exposure to HCV among persons born during 1945-1965: prevalence and predictors, United States, 1999-2008.

Authors:  Bryce D Smith; Geoff A Beckett; Anthony Yartel; Deborah Holtzman; Nita Patel; John W Ward
Journal:  Am J Public Health       Date:  2014-01-16       Impact factor: 9.308

5.  Association of hepatitis C with insulin resistance and type 2 diabetes in US general population: the impact of the epidemic of obesity.

Authors:  M Stepanova; B Lam; Y Younossi; M K Srishord; Z M Younossi
Journal:  J Viral Hepat       Date:  2011-11-09       Impact factor: 3.728

Review 6.  T cell replicative senescence in human aging.

Authors:  Jennifer P Chou; Rita B Effros
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

7.  Hepatitis C virus RNA localization in human carotid plaques.

Authors:  Maria Boddi; Rosanna Abbate; Benedetta Chellini; Betti Giusti; Carlo Giannini; Giovanni Pratesi; Luciana Rossi; Carlo Pratesi; Gian Franco Gensini; Laura Paperetti; Anna Linda Zignego
Journal:  J Clin Virol       Date:  2009-11-05       Impact factor: 3.168

8.  Effectiveness of Sofosbuvir, Ledipasvir/Sofosbuvir, or Paritaprevir/Ritonavir/Ombitasvir and Dasabuvir Regimens for Treatment of Patients With Hepatitis C in the Veterans Affairs National Health Care System.

Authors:  George N Ioannou; Lauren A Beste; Michael F Chang; Pamela K Green; Elliott Lowy; Judith I Tsui; Feng Su; Kristin Berry
Journal:  Gastroenterology       Date:  2016-06-04       Impact factor: 22.682

9.  Clinical outcomes after transfusion-associated hepatitis C.

Authors:  M J Tong; N S el-Farra; A R Reikes; R L Co
Journal:  N Engl J Med       Date:  1995-06-01       Impact factor: 91.245

10.  Insulin resistance, steatosis and hepatitis C virus.

Authors:  Alessandra Mangia; Maria Ripoli
Journal:  Hepatol Int       Date:  2013-08-27       Impact factor: 6.047

View more
  12 in total

1.  Functional Status at Liver Transplant Waitlisting Correlates With Greater Odds of Encephalopathy, Ascites, and Spontaneous Bacterial Peritonitis.

Authors:  Patrick McCabe; Grishma Hirode; Robert Wong
Journal:  J Clin Exp Hepatol       Date:  2020-04-27

Review 2.  Hepatitis C Virus in the Elderly in the Direct-Acting Antiviral Era: from Diagnosis to Cure.

Authors:  Mubeen Khan Mohammed Abdul; Heather S Snyder; Mythili Chunduru; Susan M K Lee; Sanjaya K Satapathy
Journal:  Curr Treat Options Infect Dis       Date:  2020-08-11

3.  Outcomes and predictors of treatment response with sofosbuvir plus daclatasvir with or without ribavirin in Egyptian patients with genotype 4 hepatitis C virus infection.

Authors:  Ossama A Ahmed; Mohamed A Elsebaey; Mohamed Hassan A Fouad; Heba Elashry; Ahmed I Elshafie; Ahmed A Elhadidy; Noha E Esheba; Mohammed H Elnaggar; Shaimaa Soliman; Sherief Abd-Elsalam
Journal:  Infect Drug Resist       Date:  2018-03-28       Impact factor: 4.003

4.  Epidemiology of Viral Hepatitis from 2007 to 2016 in Karbala Governorate, Iraq.

Authors:  Mohammed A Merzah; Ali Abd Al-Latif G Mohammed; Ali Neamah Hassan Al-Aaragi; Maytham Salim
Journal:  J Res Health Sci       Date:  2019-06-11

5.  Hepatitis C direct-acting antiviral outcomes in patients 75 years and older.

Authors:  Parmvir Parmar; Stephen D Shafran; Sergio M Borgia; Karen Doucette; Curtis L Cooper
Journal:  JGH Open       Date:  2020-12-18

6.  Predicting Treatment Failure for Initiators of Hepatitis C Virus Treatment in the era of Direct-Acting Antiviral Therapy.

Authors:  Nadia A Nabulsi; Michelle T Martin; Lisa K Sharp; David E Koren; Robyn Teply; Autumn Zuckerman; Todd A Lee
Journal:  Front Pharmacol       Date:  2020-11-13       Impact factor: 5.810

7.  Prevalence of Hepatitis B Virus and Hepatitis C Virus Among Blood Donors in Nekemte Blood Bank, Western Oromia, Ethiopia: Retrospective 5 Years Study.

Authors:  Milkias Abebe; Birhan Alemnew; Sirak Biset
Journal:  J Blood Med       Date:  2020-12-31

8.  Comparing Treatment Response Between Older and Younger Patients with Chronic Hepatitis C Virus Infection on Direct-acting Antiviral Agents.

Authors:  Alyssa K Francis; Francesca L Beaudoin; Safiya S Naidjate; Christine Berard-Collins; Andrew R Zullo
Journal:  R I Med J (2013)       Date:  2020-06-01

9.  Association of the Extension for Community Healthcare Outcomes Project With Use of Direct-Acting Antiviral Treatment Among US Adults With Hepatitis C.

Authors:  Linh Tran; Roger Feldman; Thomas Riley; Jeah Jung
Journal:  JAMA Netw Open       Date:  2021-07-01

10.  Disparities in the quality of care for chronic hepatitis C among Medicare beneficiaries.

Authors:  Linh Tran; Jeah Jung; Roger Feldman; Thomas Riley
Journal:  PLoS One       Date:  2022-03-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.